GALVUS NOVARTIS PDF

Novartis’ Galvus (vildagliptin) is a member of a new class of oral antidiabetic agents known as dipeptidyl peptidase IV inhibitors (DPP-IV) inhibitors or ‘incretin . Galvus Approval Status. FDA Approved: No Brand name: Galvus Generic name: vildagliptin. Previous Name: LAF Company: Novartis Pharmaceuticals. Vildagliptin is an oral anti-hyperglycemic agent (anti-diabetic drug) of the dipeptidyl The European Medicines Agency has also approved a combination of vildagliptin and metformin, vildagliptin/metformin (Eucreas by Novartis) as an oral.

Author: Maukree Zoloshakar
Country: Ethiopia
Language: English (Spanish)
Genre: Relationship
Published (Last): 26 May 2015
Pages: 495
PDF File Size: 9.77 Mb
ePub File Size: 15.62 Mb
ISBN: 504-2-54649-315-4
Downloads: 24938
Price: Free* [*Free Regsitration Required]
Uploader: Vunris

The risk or severity of hypoglycemia can be increased when Mifepristone is combined with Vildagliptin. The risk or severity of hypoglycemia can be increased when Vildagliptin is combined with Rivoglitazone.

These case studies help you bridge the gap between theoretical medicines knowledge and practical applications.

Vildagliptin – DrugBank

In these studies, vildagliptin was administered to more than 9, patients at daily doses of 50 mg once daily, 50 mg twice daily or mg once daily. Epinephrine The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Epinephrine.

Mecasermin The risk or severity of hypoglycemia can be increased when Mecasermin is combined with Vildagliptin. The risk or severity of hypoglycemia can be increased when Seletracetam is combined with Vildagliptin. Not all pack sizes may be marketed.

Galvus Approval Status

Acts as a positive regulator of T-cell coactivation, by bindi Lomefloxacin The therapeutic efficacy of Vildagliptin can be increased when used in combination with Lomefloxacin.

  INMUNOLOGIA DE KUBY PDF

Expand all Collapse all. Enalapril The risk or severity of angioedema can be increased when Enalapril is combined with Vildagliptin.

Shows how to apply the novvartis to achieve successful drug therapy. Guacetisal Guacetisal may novatris the hypoglycemic activities of Vildagliptin. The European Medicines Agency has waived the obligation to submit the results of studies with vildagliptin in all subsets of the paediatric population with type 2 diabetes mellitus see section 4.

Icandra should not be used in people who may be hypersensitive allergic to vildagliptin, metformin or any of the other ingredients. Eperisone The risk or severity of hypoglycemia can be increased when Eperisone is combined with Vildagliptin. The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Hydrochlorothiazide.

The risk or severity of hypoglycemia can be increased when Lipoic Acid is combined with Vildagliptin.

The therapeutic efficacy of Vildagliptin can be increased when used in combination with Simeprevir. The risk or severity of hypoglycemia can be increased when Miglitol is combined with Vildagliptin. Diclofenamide The therapeutic efficacy of Vildagliptin can be increased when used in combination with Diclofenamide. Vaxelis Vaxelis is a hexavalent combination vaccine indicated for active immunization Diclofenac The risk or severity of angioedema can be increased when Diclofenac is combined with Vildagliptin.

The risk or severity of angioedema can be increased when Tenecteplase is combined with Vildagliptin. In clinical trials, weight did not change from baseline when vildagliptin mg daily was administered as monotherapy Nelfinavir The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Nelfinavir. The risk or severity of angioedema can be increased when Diclofenac is combined with Vildagliptin.

  EPSON STYLUS PHOTO RX595 MANUAL PDF

The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Saquinavir. The therapeutic efficacy of Vildagliptin can be galvud when used in combination with Sulfisoxazole. Technetium Tcm ciprofloxacin The therapeutic efficacy of Vildagliptin galvhs be increased when used in combination with Technetium Tcm ciprofloxacin.

Drospirenone The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Drospirenone. Leave this field blank.

Vildagliptin launched by Novartis for dual therapy in type 2 diabetes

Deflazacort The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Deflazacort. However, the major hydrolysis metabolite LAY can be removed by haemodialysis. In a week double-blind controlled trial, vildagliptin 50 mg twice daily was compared to rosiglitazone 8 mg once daily. The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Indapamide. Ciprofloxacin The therapeutic efficacy of Vildagliptin can be increased when used in combination with Ciprofloxacin.

Sertraline The risk or severity of hypoglycemia can be increased when Sertraline is combined with Vildagliptin. The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Methylprednisolone.

Choline salicylate Choline salicylate may increase the hypoglycemic activities of Vildagliptin.